The GIPR rs1800437 polymorphism affects glucose-dependent insulinotropic peptide signaling, which works alongside GLP-1 pathways to regulate appetite and blood sugar
Together, these findings position DSIP as a multifunctional neuropeptide used in experimental models to investigate the integration of signaling pathways involved in sleep regulation, stress response, neuroprotection, and endocrine coordination
and BAGSVRD, Denmark, April 2, 2026 /PRNewswire/ -- Novo Nordisk will present the ORION study at the upcoming Obesity Medicine Association's annual conference in San Diego showing that Wegovy (semaglutide) tablets 25 mg was associated with significantly greater mean weight loss than orforglipron 36 mg in a population-adjusted indirect treatment comparison 1
This has empowered patients to ask their doctors about these medications specifically, further driving up prescription rates
And then there's the regulatory reality
Based on clinical experience and observations from weight loss through various methods, individuals who lose significant weight may develop noticeable skin laxity
